Cytosorbents Corporation (CTSO) earnings
CTSO earnings moved a median of -0.74% by the close. Quarterly and annual CTSO reports and results, each read against the price at its own news timestamp. Back to the CTSO overview →
31 measured CTSO earnings events.
Where these CTSO earnings landedvs 30 measured CTSO earnings reactions
| Middle 50% of CTSO earnings reactions | -5.96% to +4.78% |
|---|---|
| Median reaction (to close) | -0.74% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 CTSO earnings events with a measured close landed between -5.96% and +4.78%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Press release | +0.00% | -4.74% | |
| Form 10-Q Cytosorbents Corp For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.74% | |
| CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +5.74% | +5.58% | |
| CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Press release | +0.00% | -6.59% | |
| Form 10-Q Cytosorbents Corp For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.59% | |
| CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights | Press release | +0.78% | -4.69% | |
| Form 10-K/A Cytosorbents Corp For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-K Cytosorbents Corp For: Dec 31 | SEC filing · Form 10-K | -3.40% | -5.10% | |
| CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | +3.65% | -3.46% | |
| CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -2.63% | +6.45% | |
| Form 10-Q Cytosorbents Corp For: Jun 30 | SEC filing · Form 10-Q | -2.63% | +6.45% | |
| CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | +2.58% | — | |
| CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +1.06% | -0.74% | |
| Form 10-Q Cytosorbents Corp For: Mar 31 | SEC filing · Form 10-Q | +1.06% | -0.74% | |
| CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights | Press release | +0.00% | +1.82% | |
| Form 10-K Cytosorbents Corp For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit | Press release | +0.96% | -5.43% | |
| CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller | Press release | +5.00% | +0.00% | |
| CytoSorbents Reports Third Quarter 2024 Financial and Operational Results | Press release | +3.37% | -16.85% | |
| Form 10-Q Cytosorbents Corp For: Sep 30 | SEC filing · Form 10-Q | +3.37% | -16.85% | |
| CytoSorbents to Report Third Quarter 2024 Operating and Financial Results | Press release | -1.79% | +0.89% | |
| CytoSorbents Reports Second Quarter 2024 Financial and Operational Results | Press release | +6.72% | +9.15% | |
| Form 10-Q Cytosorbents Corp For: Jun 30 | SEC filing · Form 10-Q | +6.72% | +9.15% | |
| CytoSorbents to Report Second Quarter 2024 Operating and Financial Results | Press release | +0.00% | +6.86% | |
| CytoSorbents Reports First Quarter 2024 Results | Press release | -0.01% | +9.59% | |
| Form 10-Q Cytosorbents Corp For: Mar 31 | SEC filing · Form 10-Q | -0.01% | +9.59% | |
| CytoSorbents to Report First Quarter 2024 Operating and Financial Results | Press release | +2.49% | +2.38% | |
| Form 10-K Cytosorbents Corp For: Dec 31 | SEC filing · Form 10-K | -2.23% | -8.33% | |
| CytoSorbents Reports Third Quarter 2023 Financial and Operational Results | Press release | +0.00% | -11.81% | |
| Form 10-Q Cytosorbents Corp For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -11.81% | |
| CytoSorbents to Report Third Quarter 2023 Operating and Financial Results | Press release | +2.15% | -6.13% |
Keep exploring
More CTSO: analyst actions → · SEC filings → · CTSO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| argenx SE - American Depositary Shares (ARGX) | 249 | -0.02% | 48% |
| Array Technologies, Inc. (ARRY) | 249 | -0.24% | 41% |
| IRIDEX Corporation (IRIX) | 248 | +0.11% | 52% |
| Kala Pharmaceuticals, Inc. (KALA) | 248 | +0.41% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.